Head and Neck Cancer Market Value Share, Supply Demand, share and Value Chain 2019


Free Press Release DB | Press Release Date : Aug 14, 2019  Download


The market is anticipated to pursue growth strategies with a CAGR of 9.5% in the forecast period.


Head and Neck Cancer Market – Overview

The incidence of cancer has grown rapidly over the past few years at an alarming rate, among which head and neck cancer has a huge chunk. Reports that evaluate the medical device industry have been made accessible by Market Research Future, which creates reports on several industry verticals that review the market development and prospects. 

The surge in alcohol and tobacco consumed globally is often cited as a key factor contributing to the head and neck cancers. Increased detection of cancer due to the development of medical expertise and devices is projected to encourage the market in the forecast period.  Substantial developments seen in the oncology field are expected to improve the treatment methods for this type of cancer and will open up new avenues for market progress in the approaching period.

Request For Sample Report: https://www.marketresearchfuture.com/sample_request/5798

 

Segmental Analysis

The segmentation of the head and neck cancer market is conducted on the basis of the type of head and neck cancer, diagnosis, region, treatment type, and end-user. Based on the type of head and neck cancer, the market is segmented into laryngeal cancer, salivary gland cancer, pharyngeal cancer, nasopharyngeal cancer, lip and oral cavity cancer, and others. By diagnosis, the market for hand and neck cancer is segmented into blood tests, bioscopy screening tests, dental diagnosis, and endoscopy. Based on treatment type, the head and neck cancer market is segmented into surgery, radiation therapy, chemotherapy, targeted therapy, and others. The radiation therapy is additionally segmented into internal radiation therapy and external beam radiation. By end-users, the market is segmented into specialty clinics, hospitals, and ambulatory surgical centers.

Detailed Regional Analysis    

The regional assessment of the head and neck cancer market comprises of regions such as the Americas, Europe, Middle East, Asia Pacific, and Africa. The Americas region dominates the head and neck cancer market due to the incidence of a major patient population, growing prevalence of head and neck cancer, sophisticated technology, high healthcare spending, and the incidence of chief market companies. Approximately 3% of all the cancers in the USare head and neck cancer cases. The European region holds the next position in the global head and neck cancer market. It is anticipated that the research and development spending offered by the government and private organizations, growing competition among marketers, growing healthcare expenses, and adjustments in reimbursement policies in healthcare are expected to guide the European region’s head and neck cancer market. The Asia Pacific region is a rapidly increasing head and neck cancer market due to an enormous patient pool, growing demand, and the advancement of healthcare technology. The Middle East and Africa region retain the least share of the head and neck cancer market globally due to low growth, deficiency of technical knowledge, and impoverished medical facilities.

Browse Complete Report: https://www.marketresearchfuture.com/reports/head-and-neck-cancer-market-5798

Competitive Analysis

The disequilibrium noticed in the forces that are backing the growth of the market is expected to lead to a relatively slow pace of the growth. The global economies are reacting to the market forces by implementing favorable policies and cutbacks so as to prevent a slowdown in the progress of the market. The changes in the income levels globally are contributing to the growth of the market. The rise in individual discretionary spending is anticipated to lead to the progress of the market. The enhancement of the distribution channels is projected to motivate market growth relatively. The conducive nature of the monetary and fiscal policies is likely to lead to solid growth in the market. Moreover, the rise in International transactions is anticipated to bolster the expansion of the market considerably. The positive effect of the governments in the development of the market is expected to guide the market towards sound progress in the coming years.

The significant contenders in the head and neck cancer market are AbbVie Inc., Acceleron Pharma, Inc., AdDent Inc., ASAHI Roentgen, Astellas Pharma Inc., AB Science SA, Bayer AG, Siemens Healthcare, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Carestream, GE Healthcare, AstraZeneca Plc., Koninklijke Philips N.V., Identafi, NeuSoft, Shimadzu Corporation, Fujifilm Holdings, Varian Medical Systems, Xoran, and others.

 

2

Rising Incidences Set to Augment the Global Head and Neck Cancer Market

Increasing Investments Projected to Expedite Growth of the Global Head and Neck Cancer Market

 

Market Synopsis:

Initially, head and neck cancer affects squamous cells that line the mucosal surfaces and later on spread across adjoining parts such as larynx, pharynx, paranasal sinuses and nasal cavity, oral cavity, and salivary glands. Market Research Future (MRFR)’s study has found out that the global head and neck cancer market is expected to flourish in the forthcoming years reflecting a CAGR of 9.5% during the forecast period (2017 - 2023).

The occurrence of neck and head cancer is quite high. In termsof the patient population, it is the sixth leading cancer worldwide. It has necessitated the development of drugs and treatments, thus, attracting massive inflows of investments for research & development. This, in turn, is anticipated to propel the expansion of the head and neck cancer market over the next couple of years.

The major causes highlighted for head and neck cancer are smoking and drinking addictions. These addictions have become part of the lifestyle which has led to exponential growth in the number of patients. It is anticipated to create huge demand for treatments. It is likely to aid the proliferation of the head and neck cancer market in the years to come.

Request For Sample Report: https://www.marketresearchfuture.com/sample_request/5798

 

The report suggests a lucrative future trajectory for the market. However, factors such as side effects associated with treatments and high cost are expected to restrict market growth over the assessment period. Also, the lack of penetration of healthcare systems in middle and low-income nations remains an impediment to the growth pace of the head and neck cancer market.

Market Segmentation:

By type, the global head and neck market cancer market has been segmented into laryngeal cancer, lip and oral cavity cancer, pharyngeal cancer, salivary gland cancer, nasopharyngeal cancer, and others.

By diagnosis, the head and neck cancer market has been segmented into bioscopy screening tests, dental diagnosis, blood tests, imaging, and endoscopy. The bioscopy screening tests segment is further sub-segmented into fine needle aspiration biopsy, incisional biopsy, and HPV testing. The blood tests segment has been sub-segmented into total liver function tests, cell count tests, and EBV antibody measurement. The dental diagnosis segment has been sub-segmented into fluorescence visualization, acetic acid rinse method, toluidine blue dye-based method, and brush biopsy. The imaging is sub-segmented into MRI, X-ray, PET/CT, and Barium Swallow test. The endoscopy is further sub-segmented into laryngoscopy, pharyngoscopy, and others.

By treatment type, the global head and neck cancer market has been segmented into surgery, chemotherapy, targeted therapy, radiation therapy, and others. The radiation therapy is further sub-segmented into internal beam radiation and external radiation therapy.

By end-user, the head and neck cancer market has been segmented into hospitals, specialty clinics, and ambulatory surgical centers.

Browse Complete Report: https://www.marketresearchfuture.com/reports/head-and-neck-cancer-market-5798

Regional Analysis:

The global head and neck cancer market is studied across four regions – Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Americas houses a huge patient population and is poised to hold the leading share of the market in the foreseeable future. Led by the U.S., the presence of major healthcare leaders in the region is likely to have a positive impact on the growth pattern of the regional head and neck cancer market. Meanwhile, Asia Pacific is found to exhibit a drastic rise in the growth curve striking a comparatively higher CAGR.

Competitive Dashboard:

The key players profiled in MRFR’s market share analysis are AB Science SA, Acceleron Pharma, Inc., AbbVie Inc., AdDent Inc., Astellas Pharma Inc., ASAHI Roentgen, AstraZeneca Plc., Boston Biomedical, Inc., Bayer AG, Bristol-Myers Squibb Company, Fujifilm Holdings, Carestream, GE Healthcare, Koninklijke Philips N.V., Identafi, NeuSoft, Siemens Healthcare, Shimadzu Corporation, Varian Medical Systems, and Xoran.

Industry News:

In April 2019, Rodeo Therapeutic, a Seattle-based startup, has raised money for the development of tissue repair and regenerative medicines.

In April 2019, BostonGene, a biomedical software startup, has secured USD 50 Mn from NEC Corporation a multinational provider of information technology services and products, for the transformation of cancer treatments leveraging Precision Medicine Analytics.

 

Table Of Contents:

 

Chapter 1. Report Prologue

 

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

 

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

 

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

 

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

 

Chapter 6. Global Head & Neck Cancer Market, By Type

6.1 Introduction

6.2 Laryngeal Cancer

6.2.1 Market Estimates & Forecast, 2017–2023

6.3 Pharyngeal Cancer

6.3.1 Market Estimates & Forecast, 2017–2023

6.4 Salivary Gland Cancer

6.4.1 Market Estimates & Forecast, 2017–2023

6.5 Lip & Oral Cavity Cancer

6.5.1 Market Estimates & Forecast, 2017–2023

6.6 Nasopharyngeal Cancer

6.6.1 Market Estimates & Forecast, 2017–2023

6.7 Others

6.7.1 Market Estimates & Forecast, 2017–2023

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com




Contact Person & Company

Name

:

sagar pawar

Company

:

Contact Numbers

Telephone No.

:

Fax No.

:

Handphone No.

:

Website

Website 1

:

Website 2

:

Youtube

:

PR Tags

:

Head And Neck Cancer Market, Head And Neck Cancer Market Size, Head And Neck Cancer Market Trends, Head And Neck Cancer,

Address


Contact The Author








More Press Release From Author



UTI drugs Market Value Share, Supply Demand, share and Value Chain 2019


Free Press Release DB :

UTI drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections. --> Read This Press Release !



By : sagar, pawar ( Aug 14, 2019 )
Category : Healthcare Press Release | Country : India Press Release




Asia-Pacific Hospital Bed Market Value Share, Supply Demand, share and Value Chain 2019


Free Press Release DB :

The Asia-Pacific Hospital Bed Market has been analyzed as growing Market in the coming future and it is expected that the Market will have high demand in this region. --> Read This Press Release !



By : sagar, pawar ( Aug 14, 2019 )
Category : Healthcare Press Release | Country : India Press Release




Insomnia Market Value Share, Supply Demand, share and Value Chain 2019


Free Press Release DB :

The global insomnia market is all set to gain substantially from a moderate CAGR of 4.5% during the forecast period (2017-2023), claims Market Research Future (MRFR) in an extensively researched study. --> Read This Press Release !



By : sagar, pawar ( Aug 14, 2019 )
Category : Healthcare Press Release | Country : India Press Release





Disclaimer

The author of the press releases are solely responsible for the content of their press releases. Freepressreleasedb.com can't be held liable for the content posted by author. Please check the accuracy of the press release before using the press release. If necessary please contact the author. Thank you.